Charles Schwab Investment Management Inc. Reduces Stake in U.S. Physical Therapy, Inc. (NYSE:USPH)

Charles Schwab Investment Management Inc. lowered its position in U.S. Physical Therapy, Inc. (NYSE:USPH) by 4.0% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 148,901 shares of the company’s stock after selling 6,140 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in U.S. Physical Therapy were worth $12,601,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of USPH. Cetera Advisors LLC purchased a new stake in U.S. Physical Therapy in the 1st quarter valued at about $214,000. SG Americas Securities LLC boosted its stake in U.S. Physical Therapy by 37.7% in the second quarter. SG Americas Securities LLC now owns 5,924 shares of the company’s stock valued at $547,000 after acquiring an additional 1,623 shares in the last quarter. Raymond James & Associates grew its stake in U.S. Physical Therapy by 7.2% during the 2nd quarter. Raymond James & Associates now owns 18,031 shares of the company’s stock worth $1,666,000 after buying an additional 1,212 shares during the last quarter. First Horizon Advisors Inc. grew its stake in shares of U.S. Physical Therapy by 18.6% during the second quarter. First Horizon Advisors Inc. now owns 1,188 shares of the company’s stock worth $110,000 after acquiring an additional 186 shares during the last quarter. Finally, Fifth Third Bancorp increased its holdings in shares of U.S. Physical Therapy by 41.4% during the second quarter. Fifth Third Bancorp now owns 1,332 shares of the company’s stock valued at $123,000 after acquiring an additional 390 shares in the last quarter.

Insider Transactions at U.S. Physical Therapy

In other U.S. Physical Therapy news, Director Bernard A. Harris, Jr. sold 2,000 shares of the firm’s stock in a transaction on Tuesday, November 12th. The stock was sold at an average price of $92.95, for a total transaction of $185,900.00. Following the completion of the sale, the director now owns 16,726 shares of the company’s stock, valued at $1,554,681.70. This trade represents a 10.68 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Nancy Ham sold 1,172 shares of the business’s stock in a transaction dated Friday, November 8th. The shares were sold at an average price of $96.72, for a total transaction of $113,355.84. Following the completion of the sale, the director now owns 1,112 shares in the company, valued at approximately $107,552.64. This trade represents a 51.31 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 6,896 shares of company stock worth $656,940 in the last ninety days. Insiders own 1.70% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have commented on USPH shares. Bank of America reaffirmed a “neutral” rating and set a $90.00 price target (down previously from $114.00) on shares of U.S. Physical Therapy in a research report on Monday, October 7th. Barrington Research reissued an “outperform” rating and issued a $108.00 price objective on shares of U.S. Physical Therapy in a report on Thursday, November 21st. StockNews.com raised shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research note on Wednesday, August 21st. Finally, JPMorgan Chase & Co. lifted their price objective on shares of U.S. Physical Therapy from $117.00 to $120.00 and gave the company an “overweight” rating in a report on Tuesday, December 3rd.

U.S. Physical Therapy Stock Down 1.6 %

Shares of USPH opened at $96.08 on Monday. U.S. Physical Therapy, Inc. has a one year low of $76.18 and a one year high of $113.63. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.78 and a current ratio of 1.78. The stock has a 50 day moving average price of $88.04 and a 200 day moving average price of $90.09. The stock has a market capitalization of $1.45 billion, a price-to-earnings ratio of 102.21, a PEG ratio of 4.34 and a beta of 1.46.

U.S. Physical Therapy Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, December 6th. Investors of record on Friday, November 15th were given a dividend of $0.44 per share. The ex-dividend date was Friday, November 15th. This represents a $1.76 dividend on an annualized basis and a yield of 1.83%. U.S. Physical Therapy’s payout ratio is presently 187.23%.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.